MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/1471-0528.17524

Медицинская библиотека · BJOG : an international journal of obstetrics and gynaecology · 2023

Prognostic impact of cytoreductive surgery conducted with primary intent, versus cytoreductive surgery after neoadjuvant chemotherapy, in the management of patients with advanced epithelial ovarian cancers: a multicentre, propensity score-matched study from the FRANCOGYN group.

Wohrer Henri, Koual Meriem, Bentivegna Enrica, Benoit Louise, Metairie Marie, Bolze Pierre-Adrien, Kerbage Yohan, Raimond Emilie, Akladios Cherif, Carcopino Xavier, Canlorbe Geoffroy, Uzan Jennifer, Lavoue Vincent, Mimoun Camille, Huchon Cyrille, Koskas Martin, Costaz Hélène, Margueritte François, Dabi Yohann, Touboul Cyril, Bendifallah Sofiane, Ouldamer Lobna, Delanoy Nicolas, Nguyen-Xuan Huyen-Thu, Bats Anne-Sophie, Azaïs Henri

СтатьяМногоцентровое исследованиеСравнительное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVE

To compare survival and morbidity rates between primary cytoreductive surgery (pCRS) and interval cytoreductive surgery (iCRS) for epithelial ovarian cancer (EOC), using a propensity score.

DESIGN

We conducted a propensity score-matched cohort study, using data from the FRANCOGYN cohort.

SETTING

Retrospective, multicentre study of data from patients followed in 15 French department specialized in the treatment of ovarian cancer.

SAMPLE: Patients included were those with International Federation of Gynaecology and Obstetrics (FIGO) stage III or IV EOC, with peritoneal carcinomatosis, having undergone CRS.

METHODS

The propensity score was designed using pre-therapeutic variables associated with both treatment allocation and overall survival (OS).

MAIN OUTCOME MEASURES: The primary outcome was OS. Secondary outcomes included recurrence-free survival (RFS), quality of CRS and other variables related to surgical morbidity.

RESULTS

A total of 513 patients were included. Among these, 334 could be matched, forming 167 pairs. No difference in OS was found (hazard ratio, HR = 0.8, p = 0.32). There was also no difference in RFS (median = 26 months in both groups) nor in the rate of CRS leaving no macroscopic residual disease (pCRS 85%, iCRS 81.4%, p = 0.76). The rates of gastrointestinal tract resections, stoma, postoperative complications and hospital stay were significantly higher in the pCRS group.

CONCLUSIONS

Analysis of groups of patients made comparable by propensity score matching showed no difference in survival, but lower postoperative morbidity in patients treated with iCRS.

Для цитирования: Wohrer Henri, Koual Meriem, Bentivegna Enrica, Benoit Louise, Metairie Marie, Bolze Pierre-Adrien, Kerbage Yohan, Raimond Emilie, Akladios Cherif, Carcopino Xavier, Canlorbe Geoffroy, Uzan Jennifer, Lavoue Vincent, Mimoun Camille, Huchon Cyrille, Koskas Martin, Costaz Hélène, Margueritte François, Dabi Yohann, Touboul Cyril, Bendifallah Sofiane, Ouldamer Lobna, Delanoy Nicolas, Nguyen-Xuan Huyen-Thu, Bats Anne-Sophie, Azaïs Henri. Prognostic impact of cytoreductive surgery conducted with primary intent, versus cytoreductive surgery after neoadjuvant chemotherapy, in the management of patients with advanced epithelial ovarian cancers: a multicentre, propensity score-matched study from the FRANCOGYN group.. BJOG : an international journal of obstetrics and gynaecology. 2023. DOI: 10.1111/1471-0528.17524.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.